Medical device developer Neurosteer has obtained US Food and Drug Administration (FDA) approval for its single-channel electroencephalogram (EEG) brain monitoring platform.
The company has embellished the standard EEG system with an adhesive-backed electrode strip connected to a pocket-sized sensor.
The sensor accepts the signal from the electrode strip and transmits it to the brain activity monitor, which displays the status information alongside the most recently acquired signal.
